|
BioLineRx to initiate Phase 1/2 clinical trial on new drug candidate for CML …
News-Medical.net Arnon Nagler, Director of the Hematology Division and Bone Marrow Transplantation Center at Sheba Medical Center, Israel, has received final regulatory approval to evaluate BioLineRx’s BL-8040 as a treatment for chronic myeloid leukemia (CML) in a … |
|
Ultimate Warrior predicted own death by warning about heart failure
Business Standard Wrestling champion Ultimate Warrior chillingly predicted his death 20 hour before he actually died by warning about heart failure. The 54-year-old wrestler, born Jim Hellwig, spoke to WWEs flagship show RAW where he said that every man’s heart one day … |
Research and Markets: US Therapeutic Drug Monitoring (TDM) Market 2014 …Business Wire (press release)… Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Q…
Xencor Receives Milestone Payment from Merck for Initiation of Phase 1 …PharmiWeb.com (press release)MONROVIA Calif. April 10 2014 /PRNewswire/ — Xencor Inc. (NASDAQ: XNCR) a clinical-stage biopharmaceutical company developing engineered monoclonal …
Xencor Receives Milestone Payment from Merck for Initiation of Phase 1 …MarketWatchMONROVIA, Calif., April 10, 2014 /PRNewswire/ — Xencor, Inc. (NASDAQ:XNCR) , a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies fo…
|
Copper drugs can block cancer growth
Business Standard “Oral drugs used to lower copper levels in Wilson disease could be repurposed to treat BRAF-driven cancers like melanoma, or perhaps even others like thyroid or lung cancer,” said Donita C Brady, lead author of the study. A clinical trial has already … |
Medical Xpress |
Study may help heart failure through the Parachute Ventricular Partitioning Device
Medical Xpress Zachary Gertz, M.D., of Virginia Commonwealth University’s Pauley Heart Center is leading a new study at VCU to monitor the effects of the Parachute Ventricular Partitioning Device, which may help in the treatment of heart failure. The trial will … Study may help heart failure through Parachute DeviceHealthCanal.com |
|
ProMetic’s PBI-4050 Delivers New Positive Preclinical Results in Liver …
SYS-CON Media (press release) Liver transplantation is the only treatment available for patients with advanced stage of fibrosis. About ProMetic Life Sciences Inc. ProMetic Life Sciences Inc. (www.prometic.com) is a long established biopharmaceutical company with globally … |
BioLineRx Announces Investigator-Initiated Study for Novel Chronic Myeloid …MarketWatchPre-clinical studies show that BL-8040 is efficient, both alone and in combination with anti-cancer drugs such as Rituximab, Imatinib and Bortezomib in lymphoma, C…
|
BioLineRx (BLRX) Approved to Evaluate BL-8040 as CML Treatment in Phase 1 …
StreetInsider.com (subscription) BioLineRx (Nasdaq: BLRX) announced that Prof. Arnon Nagler, Director of the Hematology Division and Bone Marrow Transplantation Center at Sheba Medical Center, Israel, has received final regulatory approval to evaluate BioLineRx’s BL-8040 as a … |